Patents by Inventor Klaus J. Busam

Klaus J. Busam has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma
    Patent number: 7267951
    Abstract: A tissue or biopsy sample is evaluated to determine if the sample is early-stage melanoma by determining the level of inhibitor of DNA-binding protein 1 (Id1) expression in cells of the sample; and comparing the determined amount of Id1 to a reference level. The presence of levels of Id1 in cells of the sample in excess of the reference level indicates that the sample is early-stage melanoma.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: September 11, 2007
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Rhoda M. Alani, Alison Z. Young, Klaus J. Busam
  • Method for evaluating a tissue or biopsy sample to determine if the sample is early-stage melanoma
    Publication number: 20040014114
    Abstract: A tissue or biopsy sample is evaluated to determine if the sample is early-stage melanoma by determining the level of inhibitor of DNA-binding protein 1 (Id1) expression in cells of the sample; and comparing the determined amount of Id1 to a reference level. The presence of levels of Id1 in cells of the sample in excess of the reference level indicates that the sample is early-stage melanoma.
    Type: Application
    Filed: June 3, 2003
    Publication date: January 22, 2004
    Inventors: Rhoda M. Alani, Alison Z. Young, Klaus J. Busam